Institute for Maternal and Child Health - IRCCS Burlo Garofolo, Trieste, Italy.
Transfusion Medicine Department, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy.
Front Immunol. 2024 Aug 9;15:1427349. doi: 10.3389/fimmu.2024.1427349. eCollection 2024.
Type 1 diabetes is an autoimmune disease with an significant genetic component, played mainly by the class II genes. Although evidence on the role of class I genes in developing type 1 diabetes and its onset have emerged, current screening is limited to determining DR3 and DR4 haplotypes. This study aimed to investigate the role of genes on type 1 diabetes risk and age of onset by extensive typing.
This study included 115 children and young adults with type 1 diabetes for whom typing of , , , , , , , and genes was conducted using Next Generation Sequencing.
We observed that 13% of type 1 diabetes subjects had non-classical haplotypes that predispose to diabetes. We also found that compared to type 1 diabetes subjects with classical haplotypes, non-classical subjects had a significantly higher frequency of (p-value=0.01) and (p-value=0.03) alleles, known to be involved in activating the immune response. Non-classical subjects also presented peculiar clinical features compared to classical HLA subjects, such as multiple diabetic antibodies and the absence of other autoimmune diseases (i.e., coeliac disease and thyroiditis). We also observed that subjects with early onset had a higher frequency of DQ2/DQ8 genotype than late-onset individuals. Moreover, subjects with late-onset had a higher frequency of alleles (p-value=0.003), (p-value=0.027) and (p-value=0.01), known to be associated with increased protection against viral infections.
This study reveals a broader involvement of the locus in the development and onset of type 1 diabetes, providing insights into new possible disease prevention and management strategies.
1 型糖尿病是一种自身免疫性疾病,具有重要的遗传成分,主要由 II 类基因发挥作用。尽管有关 I 类基因在 1 型糖尿病发病及其发病年龄中的作用的证据已经出现,但目前的筛查仅限于确定 DR3 和 DR4 单倍型。本研究旨在通过广泛的基因分型来研究 基因在 1 型糖尿病发病风险和发病年龄中的作用。
本研究纳入了 115 名 1 型糖尿病患儿和青年,对其进行了 基因、 基因、 基因、 基因、 基因、 基因和 基因的下一代测序分型。
我们发现,13%的 1 型糖尿病患者存在易患糖尿病的非经典 单倍型。我们还发现,与具有经典 单倍型的 1 型糖尿病患者相比,非经典 患者具有显著更高的 (p 值=0.01)和 (p 值=0.03)等位基因频率,已知这些等位基因参与激活免疫反应。与经典 HLA 患者相比,非经典 患者还表现出独特的临床特征,如多种糖尿病抗体和缺乏其他自身免疫性疾病(即乳糜泻和甲状腺炎)。我们还观察到,早发患者的 DQ2/DQ8 基因型频率高于晚发患者。此外,晚发患者的 (p 值=0.003)、 (p 值=0.027)和 (p 值=0.01)等位基因频率更高,这些等位基因与增加对病毒感染的保护作用有关。
本研究揭示了 基因在 1 型糖尿病发病和发病年龄中的更广泛参与,为新的可能的疾病预防和管理策略提供了见解。